Phase I Open and Monocentric Clinical Trial With Pharmacokinetic and Pharmacodynamic Determination of Subcutaneous Recombinant Human Erythropoietin in Male Adults
Latest Information Update: 05 Apr 2024
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Megalabs
- 08 Apr 2022 Planned End Date changed from 1 Mar 2022 to 1 Dec 2023.
- 08 Apr 2022 Planned primary completion date changed from 1 Dec 2021 to 1 Mar 2023.
- 08 Apr 2022 Planned initiation date changed from 1 Sep 2021 to 1 Jan 2023.